Grassley Renews Call For Permanent FDA Commissioner
This article was originally published in The Pink Sheet Daily
Senate Finance Committee Chairman Charles Grassley (R-Iowa) repeated his request that the Administration nominate an FDA commissioner
You may also be interested in...
The HHS Office of the Inspector General has issued multiple subpoenas as part of its ongoing review of former FDA Commissioner Lester Crawford
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.